美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

健康照護類股ETF-SPDR

167.66

-0.0900-0.05%

盤後：167.660.00000.00%17:49 EDT

成交量：742.85萬

成交額：12.43億

市值：435.35億

市盈率：-11.79

高：168.20

開：167.79

低：166.18

收：167.75

52周最高：176.60

52周最低：133.73

股本：2.60億

流通股本：2.60億

量比：0.86

換手率：2.86%

股息：2.53

股息率：1.51%

每股收益(TTM):-14.2170

每股收益(LYR):-14.2170

淨資產收益率：-9.22%

總資產收益率：1.03%

市淨率：1.27

市盈率(LYR):-11.79

資料載入中...

總覽公司新聞資訊公告

摩根士丹利：Grindr醫療健康業務藴藏巨大商機

醫療保健板塊動態匯總：市場快訊

Tenet Healthcare（THC）擬私募發行15億美元票據，置換到期債務

大家人壽9.8億元投資接力基金後者投向硬科技、醫療健康等領域

泰達生物(08189)與星辰通用簽署戰略合作框架協議共同推動醫療健康具身智能技術體系、產品體系和解決方案的形成與產業化落地

英國藥品和醫療保健產品監管局已受理Biosplice公司關於洛雷西文特治療膝骨關節炎的申請，並正式啓動評估程序。

羅兵咸永道、默克與哈希圖集團試點可可溯源系統

醫療保健板塊市場快訊匯總

商務部新增84個全國重點外資項目

醫療保健板塊動態：市場快訊匯總

醫療保健板塊市場快訊匯總

2070元/月，佛山這筆錢上調

醫療健康板塊動態：市場快訊匯總

諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影

人保健康保險大連分公司被罰27萬，涉聘任不合格人員等

研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方

醫療健康板塊動態：市場快訊匯總

丹陽家長注意！2027年度學生醫保繳費啓動

一項針對僱主的調查預計，美國醫療保健成本將出現20多年來最大漲幅：2027年僱主提供的醫療保險成本預計將較今年上升8.2

醫療板塊市場快訊：和黃醫藥與GSK達成許可協議，AstraZeneca新藥前景獲看好

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/XLV/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照護類股ETF-SPDR","latestPrice":167.66,"timestamp":1789502400000,"preClose":167.75,"halted":0,"volume":7428529,"hourTrading":{"tag":"盘后","latestPrice":167.66,"preClose":167.66,"latestTime":"17:49 EDT","volume":290291,"amount":48670218.0891,"timestamp":1789508963899,"change":0,"changeRate":0,"amplitude":0.005786},"delay":0,"changeRate":-0.000536512667660229,"floatShares":259665324,"shares":259665324,"eps":-14.217021,"marketStatus":"盤後交易","change":-0.09,"latestTime":"09-15 18:01:39 EDT","open":167.79,"high":168.2,"low":166.1783,"amount":1242805381.62872,"amplitude":0.012052,"askPrice":168.6,"askSize":500,"bidPrice":167.27,"bidSize":100,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":167.75,"sharesOutstanding":265215324,"nav":165.417085,"aum":42977893449.49,"dividendRate":0.015108,"bidAskSpread":0.000121,"preHourTrading":{"tag":"盘前","latestPrice":168.1,"preClose":167.75,"latestTime":"09:29 EDT","volume":7026,"amount":1180262.82078,"timestamp":1789478999999,"change":0.35,"changeRate":0.002086,"amplitude":0.007541},"postHourTrading":{"tag":"盘后","latestPrice":167.66,"preClose":167.66,"latestTime":"17:49 EDT","volume":290291,"amount":48670218.0891,"timestamp":1789508963899,"change":0,"changeRate":0,"amplitude":0.005786},"volumeRatio":0.864909,"impliedVol":0.1802,"impliedVolPercentile":0.5418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":259665324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.864909,"shares":259665324,"dividePrice":2.533,"high":168.2,"amplitude":0.012052,"preClose":167.75,"low":166.1783,"week52Low":133.725,"pbRate":"1.27","psRate":"66.09","week52High":176.595,"institutionHeld":0.7846,"latestPrice":167.66,"committee":-0.666667,"eps":-14.217021,"divideRate":0.015108,"volume":7428529,"delay":0,"ttmEps":-14.217021,"open":167.79,"prevYearClose":154.8,"prevWeekClose":165.36,"prevMonthClose":170.54,"prevQuarterClose":158.66,"fiveDayClose":167.13,"twentyDayClose":167.05,"sixtyDayClose":149.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1183339770","title":"摩根士丹利：Grindr醫療健康業務藴藏巨大商機","url":"https://stock-news.laohu8.com/highlight/detail?id=1183339770","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183339770?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:42","pubTimestamp":1788892936,"startTime":"0","endTime":"0","summary":"美东时间14:40——Grindr或将演变为一家披着约会应用外衣的医疗健康企业。该公司已借旗下Woodwork业务涉足远程医疗领域，该业务主要提供勃起功能障碍等病症的治疗药物。然而，摩根士丹利分析师在与Grindr管理层会晤后发布的研报中指出，Grindr的\"医疗健康雄心远不止于Woodwork\"。管理层认为，未来的健康相关收入机遇有望超越其核心业务规模。该公司正积极布局性传播疾病的预防与管理领域，并着眼于长远，旨在为平台用户提供全方位的临床医疗服务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","GRND","IE00B3S45H60.SGD","LU0029874061.USD","LU2133065610.SGD","HCSG","LU2271345857.HKD","BK4127","LU0882574139.USD","IE00B775SV38.USD","LU1244550494.USD","IAI","LU0557290698.USD","LU0971096721.USD","LU1668664300.SGD","LU1791710582.SGD","LU1064131342.USD","LU1988902786.USD","LABU","LU2111349929.HKD","LU2264538146.SGD","LU0158827781.USD","LU1162221912.USD","LU2023251221.USD","BK4588","BK4504","LU1244550221.USD","XBI","LU0225283273.USD","LU1244550577.SGD","IE00BKVL7J92.USD","LU2357305700.SGD","LU0795875169.SGD","LU1989772923.USD","MS","LU2487616109.SGD","LU1791710400.SGD","BK4585","LU0106831901.USD","LU0158827948.USD","LU0390134368.USD","BK4534","BK4516","LU0795875086.SGD","LU2089284900.SGD","LU0210528500.USD","LU0314104364.USD","LU1074936037.SGD","LU1732800096.USD","LU2028103732.USD","LU0912757837.SGD","SOCL","LU1363072403.SGD","LU2347655156.SGD","LU0267386448.USD","LU0128526141.USD","XLV","LU1732799900.SGD","LU0053666078.USD","LU0528227936.USD","LU1548497426.USD","BK4077","LU0098860793.USD","LU1720051108.HKD","LU2089283258.USD","BK4581","LU0006306889.USD","LU1720051017.SGD","LU0234570918.USD","LU0106261372.USD","LU0320765646.SGD","BK4137","IE00BZ1G4Q59.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112978991","title":"醫療保健板塊動態匯總：市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1112978991","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112978991?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:23","pubTimestamp":1788884589,"startTime":"0","endTime":"0","summary":"最新一期医疗保健板块市场快讯，涵盖行业动向与个股表现，于美国东部时间4:20、12:20及16:50通过道琼斯通讯社独家发布。该公司股价应声下跌10%。杰富瑞称，肾病药物Voyxact及其他自有资产正逐步取代合作产品，成为这家日本制药企业的主要收入驱动力。随着这一转型持续推进，该行预计利润增速将快于收入增速。杰富瑞将大冢目标价从12,700日元上调至14,000日元。该公司股价小幅上涨0.3%，报11,770日元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665753923","title":"Tenet Healthcare（THC）擬私募發行15億美元票據，置換到期債務","url":"https://stock-news.laohu8.com/highlight/detail?id=2665753923","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665753923?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:15","pubTimestamp":1788873326,"startTime":"0","endTime":"0","summary":"金吾财讯 | Tenet Healthcare（THC）周二公布债务操作计划，拟通过私募方式发行15亿美元、2034年到期的全新优先票据，用于对同等规模存量债务实施再融资。本次发行所得净资金，搭配公司现有现金，将全额赎回2027年11月到期，票面利率5.125%的优先有担保第一留置权票据。新票据属于无担保优先债务，和公司当前以及未来的其他无担保优先债务享有同等清偿顺位。本次票据发行还需要完成定价流程，并满足各类常规交割条件。票据仅依据相关证券豁免规则，面向合格机构投资者进行发售。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/MDE2NGUxYWJlMGQ4OGQwMTU5ZTY5YzEzNTY0MzU1Mzgx.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDE2NGUxYWJlMGQ4OGQwMTU5ZTY5YzEzNTY0MzU1Mzgx.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861165.SGD","LU2324357040.USD","XLV","XBI","BK4581","BK4585","LU0130103400.USD","THC","LU0648000940.SGD","BK4185","LABU","LU0963586101.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665273123","title":"大家人壽9.8億元投資接力基金 後者投向硬科技、醫療健康等領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2665273123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665273123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:25","pubTimestamp":1788866725,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XBI","IXJ","VHT","BK4585","BK4581","BK4550","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324454","title":"泰達生物(08189)與星辰通用簽署戰略合作框架協議 共同推動醫療健康具身智能技術體系、產品體系和解決方案的形成與產業化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324454","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324454?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:40","pubTimestamp":1788864000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰达生物 公布，公司与湖南星辰通用机器人有限公司已签署战略合作框架协议。双方将本着平等自愿、优势互补、场景牵引、联合创新、资源共享、长期合作的原则，围绕医疗健康大模型与具身智能技术的深度融合，共同推动医疗健康具身智能技术体系、产品体系和解决方案的形成与产业化落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4581","IXJ","XLV","159760","BK4585","BK4550","XBI","LABU","BK4588","WDRN","08189","BK1113","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665654324","title":"英國藥品和醫療保健產品監管局已受理Biosplice公司關於洛雷西文特治療膝骨關節炎的申請，並正式啓動評估程序。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665654324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665654324?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 18:33","pubTimestamp":1788863626,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","CGVV","NOBL","VHT","BK4588","BK4581","BK4550","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665370321","title":"羅兵咸永道、默克與哈希圖集團試點可可溯源系統","url":"https://stock-news.laohu8.com/highlight/detail?id=2665370321","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665370321?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:48","pubTimestamp":1788860926,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，The Hashgraph Group 与默克公司（Merck）在普华永道德国（PwC Germany）的咨询与实施支持下，正试点一套可可溯源解决方案。该方案将默克的 M-Trust 物理认证技术与基于 Hedera 网络的 TrackTrace 数字产品护照平台相结合，旨在验证可可从农场到消费者的产地、真实性、质量、召回需求及合规数据。可可属于欧盟《反毁林法规》（EUDR）覆盖的七种商品之一。根据 2025 年 12 月达成的再次延期安排，大型运营商和贸易商须自 2026 年 12 月 30 日起履行相关义务，微型和小型运营商则从 2027 年 6 月 30 日起适用。该方案还对标欧盟《可持续产品生态设计法规》（ESPR）下数字产品护照的推进方向，不过食品和饲料目前被明确排除在 ESPR 范围之外，对可可而言，EUDR 尽职调查仍是近期约束性要求。合作伙伴表示，该架构不限于可可，未来可扩展至药品、奢侈品和工业组件等领域。普华永道德国企业区块链业务负责人 Husen Kapasi 指出，该方案具备可验证性，在食品召回或合规调查中能够发挥关键作用。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2288251","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","JDOC","LU1699723380.USD","LU1941712348.USD","LU2491049909.HKD","LU0106261372.USD","RXL","SG9999013999.USD","LU0689626769.HKD","BK4533","LU1571399168.USD","LU0980610538.SGD","XLV","LU0868494708.USD","LU0070302665.USD","LU0234572021.USD","LU2324357040.USD","LU0208291251.USD","BK4588","SG9999002224.SGD","LU0861579265.USD","LU1037948541.HKD","SG9999015358.SGD","BK4516","IE000M9KFDE8.USD","SG9999002232.USD","BK4534","LU0320765646.SGD","IE00BJT1NW94.SGD","FHLC","LU2125909593.SGD","FTXH","LU2023250504.SGD","LU0124676726.USD","LU0130517989.USD","LU0238689110.USD","LU1093756325.SGD","LU1057294990.SGD","LU1989771016.USD","LU2125909247.SGD","LU2089984988.USD","LU1116320737.USD","LU0432979614.USD","LU0211331839.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU1934455863.HKD","LU1989772840.SGD","LU1066051811.HKD","IE00BLSP4452.SGD","LU0985320562.USD","LU1291159041.SGD","SG9999015341.SGD","SGXZ57979304.SGD","LU2433249047.HKD","LU0965509101.SGD","SG9999014567.USD","LU1037948897.HKD","LU1929549753.HKD","LU0868494617.USD","BMED","LU0289739699.SGD","LU2023250843.SGD","LU2361044949.HKD","LU2106854487.HKD","IE00B1BXHZ80.USD","GDOC","LU1035773651.USD","SG9999001176.USD","LU2360032135.SGD","LU1923622614.USD","LU0965509010.AUD","LU1941712264.USD","MRK","PAWZ","LU1989772923.USD","PPH","LU1934455194.USD","LU0965508806.USD","IXJ","LU2491050071.SGD","LU2125154778.USD","SG9999001440.SGD","LU0006306889.USD","LU1032466523.USD","IE00BLSP4239.USD","LU1917777945.USD","SG9999014559.SGD","VHT","LU2361045086.USD","IE00B4R5TH58.HKD","TRUH","LU0265550359.USD","LU0320765489.SGD","LU0265550946.USD","SG9999001176.SGD","IHE","BK4007","SG9999014575.USD","LU1201861249.SGD","LU1430594728.SGD","HRTS","LU0965509283.SGD","LU0130102774.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU0477156953.USD","LU0823416689.USD","LU0122379950.USD","LU1061106388.HKD","BK4550","LU0058720904.USD","LU0203347892.USD","LU0648001328.SGD","LU1066053197.SGD","IE0009355771.USD","LU2357627491.SGD","LU0266013472.USD","IE00BSNM7G36.USD","LU2125154935.USD","IE0002141913.USD","LU2491050154.USD","BK4559","LU0203345920.USD","LU1066051225.USD","LU1983299246.USD","LU2361044865.SGD","LU1023059063.AUD","LU0859254822.USD","LU1585245621.USD","LU1066051498.USD","LU1162221912.USD","LU1934455277.USD","LU2461242641.AUD","BK4585","LU1093756168.USD","SG9999014542.SGD","LU1069347547.HKD","LU2112291526.USD","LU0942090050.USD","IE00BN8TJ469.HKD","LU1116320901.HKD","IYH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169238098","title":"醫療保健板塊市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1169238098","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169238098?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:25","pubTimestamp":1788855909,"startTime":"0","endTime":"0","summary":"不过，分析师注意到，公司对2030年后实现中个位数百分比增长的雄心未作任何表态。杰富瑞认为，即便近期一款多发性硬化症口服新药取得了成功，但若缺少del-desiran和del-brax这两款自Avidity Biosciences收购而来的药物，要确立市场对公司2030年代增长前景的信心仍面临重重挑战。该公司股价下挫10%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341019","title":"商務部新增84個全國重點外資項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341019","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341019?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 12:05","pubTimestamp":1788840300,"startTime":"0","endTime":"0","summary":"【大河财立方记者程帅星厦门报道】9月8日，大河财立方记者在第二十六届中国国际投资贸易洽谈会(以下简称“投洽会”)上获悉，商务部近日新增84个全国重点外资项目，其中包括6个外资标志性项 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260908/c679692496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU2756315318.SGD","LU2168563687.JPY","SKHZ","LU1989771016.USD","LU0158827781.USD","LU2328871848.SGD","LU2168564065.EUR","LU1093756325.SGD","LU2462591350.SGD","LU2471134523.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU1023059063.AUD","IE00BWXC8680.SGD","LU2471134796.USD","LU0097036916.USD","CURE","LU0964807845.USD","SKHY","SKHN","BK0188","LU2089283258.USD","LU2360106947.USD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU0823426480.USD","SGXZ31699556.SGD","LU0823397103.USD","LU1974910355.USD","LU1323610961.USD","LU0979878070.USD","LU2265009873.SGD","LU0058720904.USD","SG9999015986.USD","LU0516422366.SGD","BK1589","LU2361044949.HKD","LU1794554557.SGD","LU2236285917.USD","VHT","LU2461242641.AUD","LU0823413587.USD","LU2552382215.SGD","IE00B775H168.HKD","LU2750360997.AUD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2111349929.HKD","BK0028","LU0823416689.USD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU0353189763.USD","LU0122379950.USD","LU1868837136.USD","LU2237443465.HKD","LU1280957306.USD","LU0689472784.USD","LU0096364046.USD","LU2491049909.HKD","LU0456855351.SGD","SKUU","LU0354030438.USD","IE0004445015.USD","LU2746668461.USD","LU0787776722.HKD","LU0466842654.USD","LU1629891620.HKD","LU2213496289.HKD","IE0001KFT4U8.USD","SG9999018857.SGD","SG9999014898.SGD","LU0327786744.USD","LU0823413660.USD","RXL","SG9999001176.SGD","LU0052750758.USD","SGXZ81514606.USD","AGNG","LU0516422440.USD","GDOC","LU2168564222.USD","LU0856984785.SGD","LU0114720955.EUR","LU2750360641.GBP","LU0708995401.HKD","LU0234572021.USD","LU0348825331.USD","LU1814569148.SGD","SG9999002463.SGD","LU1983299246.USD","SKHYV","IHE","LU0823434583.USD","LU2237438978.USD","LU2237443978.SGD","LU2271345857.HKD","LU1988902786.USD","LU0051755006.USD","LU0109394709.USD","LU2746668974.SGD","IE00BK4W5L77.USD","LU0326950275.SGD","MEDI","LU2357305700.SGD","LU0471298777.SGD","SG9999015978.USD","BK0208","LU0079474960.USD","LU3063872942.SGD","LU1691799644.USD","WDNA","LU2471134879.HKD","LU0029864427.USD","LU0203201768.USD","BK4568","HRTS","LU0128526141.USD","LU1969619763.USD","SKHA","LU2324357040.USD","IE00BJLML261.HKD","MHIP","LU0006306889.USD","LU1069344957.HKD","LU1880383366.USD","IE00B2B36J28.USD","LU1242518931.SGD","LU1720050803.USD","LU0819121731.USD","LU0348735423.USD","LU1868836757.USD","LU0882574139.USD","IYH","BK4533","BK4599","LU2063271972.USD","PPH","LU0029874061.USD","LU2089284900.SGD","LU1868837300.USD","SG9999017495.SGD","LU2211815571.USD","LU0174119429.USD","LU2361044865.SGD","LU1548497426.USD","ILDR","LU0359202008.SGD","LU0225283273.USD","LU2756315664.SGD","LU2468319806.SGD","LU2168564149.EUR","LU1551013425.SGD","LU2417539215.USD","IE00B4R5TH58.HKD","LU2462157665.USD","LU1688375341.USD","SG9999015952.SGD","LU0572944931.SGD","LU0640476718.USD","SGXZ57979304.SGD","SG9999018865.SGD","LU0203202063.USD","LU0256863811.USD","LU0516422952.EUR","LU0823426308.USD","LU1868836591.USD","LU0417516738.SGD","LU2552382058.USD","LU1035775433.USD","IE00B7KXQ091.USD","LU2106854487.HKD","BK0197","LU0198837287.USD","SG9999002562.SGD","LU0238689110.USD","LU2023250330.USD","LU2237443382.USD","LU1242518857.USD","LU1145028129.USD","TMED","IE00B1BXHZ80.USD","BK4581","LU0181495838.USD","MEDX","LLII","TRUH","LLYX","BK1521","LU0516423174.USD","LU1551013342.USD","IE00B3T34201.USD","LU2602419157.SGD","LU2108987350.USD","LU1291159041.SGD","LU2491050154.USD","LU0345770308.USD","LU0359201612.USD","LU1868836914.USD","LU1720051017.SGD","LU2028103732.USD","LU2552382132.HKD","LU0266013472.USD","LU2491050071.SGD","SG9999014880.SGD","LU2023251221.USD","LU2237443549.SGD","LU1979441026.SGD","LU2087625088.SGD","KURE","LU0289739699.SGD","LU0133085943.USD","LU2039709279.SGD","LU0943347566.SGD","LU1366192091.USD","LU0316494557.USD","LU1956131251.USD","LU0820561909.HKD","LU0210536198.USD","BK4585","IE0009355771.USD","LU1917777945.USD","IE0004445239.USD","BK4141","02269","IE0005OL40V9.USD","IE00BJJMRY28.SGD","BK1576","LU0823434740.USD","LU0385154629.USD","LU2168564495.EUR","LU0106261372.USD","LU1829250122.USD","IE00BKPKM429.USD","LU0417517546.SGD","PJP","IE00BJJMRX11.SGD","LU0889565916.HKD","LU2471134952.CNY","SG9999013999.USD","LU1232071149.USD","LU0310800379.SGD","SKHQ","BK1141","LU0471298694.HKD","LU0323591593.USD","IE00BJJMRZ35.SGD","THNR","LU0786609619.USD","SKHU","07709","SKHL","LLY","LU2896262040.SGD","LU0320765992.SGD","LU0158827948.USD","LU1127390331.HKD","IE0002141913.USD","LU0109391861.USD","BK4007","LU1057294990.SGD","LU0820561818.USD","AZNH","IE00BN29S564.USD","ELIL","LU2456880835.USD","OZEM","LU0039217434.USD","SKDD","FTXH","LU0672654240.SGD","WXXWY","LU0516423091.SGD","GB00BDT5M118.USD","BK4534","LU0456846285.SGD","LU0432979614.USD","LU1064131342.USD","LU0353189680.USD","LU2237443895.HKD","LU0708994859.HKD","LU0320765059.SGD","LU0820562030.AUD","LU2023250504.SGD","AZN","LU1267930573.SGD","JDOC","LU0354030511.USD","IE00BKDWB100.SGD","ABB","LU2237443622.USD","LU0588546209.SGD","LU0140636845.USD","HYNX","IE00BFSS7M15.SGD","LU0456827905.SGD","XLV","SG9999014914.USD","LU1093756168.USD","LU0094547139.USD","BK4096","SKHX","LU0683600562.USD","IXJ","LU1061106388.HKD","LU2089984988.USD","LU2361045086.USD","IE00BFSS8Q28.SGD","LU0708995583.HKD","BK0196","SGXZ51526630.SGD","LU1804176565.USD","LU1623119135.USD","LU0128525929.USD","LU0320764599.SGD","LU0307460666.USD","CANC","SK","SG9999014906.USD","BK4588","ELIS","BK4516","LU1712237335.SGD","SG9999015945.SGD","LU0823397285.USD","LU2112291526.USD","LU0417516902.SGD","LLYZ","BK1610","FHLC","LU1720051108.HKD","IE00BK4W5M84.HKD","BK0187","LU0256863902.USD","LU0345770993.USD","LU0882574055.USD","LU0043850808.USD","IE00B0JY6N72.USD","002493","LU1267930730.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166930636","title":"醫療保健板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1166930636","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166930636?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 04:52","pubTimestamp":1788814379,"startTime":"0","endTime":"0","summary":"1035 ET - 杰富瑞分析师指出，阿斯利康凭借其新药Ectamah正在开辟乳腺癌治疗的全新范式，该药刚刚获得美国食品药品监督管理局的上市许可。分析师们认为，这无疑是近年来乳腺癌领域最具分量的批准之一。尽管Ectamah的获批具有重大临床意义，但杰富瑞也提醒，目前其适用人群仅为全体乳腺癌患者中的一部分，这在短期内限制了其商业价值。该公司股价小幅上扬0.5%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4581","BK4585","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124637396","title":"醫療保健板塊市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1124637396","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124637396?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 00:22","pubTimestamp":1788798177,"startTime":"0","endTime":"0","summary":"1035 GMT——杰富瑞分析师指出，阿斯利康凭借其新药Ectamah，正在开启乳腺癌治疗的全新范式，该药物刚刚获得美国食品药品监督管理局的批准。分析师评价，这堪称近年来乳腺癌领域最具分量的审批之一。不过杰富瑞也提醒，尽管Ectamah获批在临床上意义重大，但目前其适用人群仅为全体乳腺癌患者中的特定亚群，这在一定程度上限制了其商业价值。该公司股价上涨0.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315217","title":"2070元/月，佛山這筆錢上調","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315217","media":"珠江时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315217?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775200,"startTime":"0","endTime":"0","summary":"随着佛山市最低工资标准9月1日失业金自待遇所属期2026年9月起上调至2070元/月。（二）享受的待遇标准1、失业保险金：按我市企业职工最低工资标准的90%按月发放，待遇所属期2026年9月起是2070元/月。大龄领金人员达到法定退休年龄时，或出现停止领取失业保险金情形的，停止享受由失业保险基金继续承担企业职工基本养老保险费。2025年2月1日及之后申请失业保险金的失业人员，按修改后的省条例执行，不再发放求职补贴。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-07/doc-iniqyzxu6360828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LABU","BK4585","XBI","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175448508","title":"醫療健康板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1175448508","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175448508?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:23","pubTimestamp":1788769386,"startTime":"0","endTime":"0","summary":"0727 GMT——CGS国际分析师Kasem Prunratanamala在研报中指出，Klinique医疗诊所上调了2026年营收指引，但这一利好消息似乎已被市场提前消化。这家医疗美容诊所运营商将2026年营收目标从41.5亿泰铢上调至45亿泰铢，理由是7月份现金销售增长强劲。尽管公司运营势头稳健，同店销售增长韧性十足，但近期股价的强势表现已充分反映了大部分正面消息。该券商维持该股\"持有\"评级及28.00泰铢的目标价。目前股价报29.00泰铢，上涨1.75%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","BK4581","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665699390","title":"諾華降膽固醇藥物遭遇挫折，令人們對新興心臟病藥物的期望蒙上陰影","url":"https://stock-news.laohu8.com/highlight/detail?id=2665699390","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665699390?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768711,"startTime":"0","endTime":"0","summary":"罕见病药物备受期待市场关注点现将转向第四季度其RNA疗法del-desiran的后期临床试验结果。该药物用于治疗一种罕见肌肉疾病，系通过收购Avidity公司获得。诺华公司另一款抗炎药物雷米布替尼针对一种名为脓疱性汗腺炎的皮肤病所开展的研究数据，预计也将于今年公布。该药物上周在多发性硬化症患者的临床试验中取得了成功。这两家竞争对手的药物均在与佩拉卡森类似的临床试验中进行测试，这些试验依赖于确诊的心脏相关事件，且没有明确的结束日期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL4T44Z0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","HRTS","AMGN","CANC","XLV","JDOC","BIB","AGNG","LLYZ","TBXU","LU2746668974.SGD","MHIP","GDOC","MEDX","OZEM","LU1551013425.SGD","PPH","ELIL","LLII","PJP","MEDI","VHT","SLN","LU0456855351.SGD","LLY","LU1988902786.USD","LU2491049909.HKD","IE00BK4W5L77.USD","TMED","IBB","IXJ","LU0096364046.USD","THNR","FTXH","LU2324357040.USD","BK4588","ELIS","IYH","NAMS","RXL","LLYX","CURE","IBBQ","WDNA","BK4581","BBH","PBE","TRUH","IHE","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665954553","title":"人保健康保險大連分公司被罰27萬，涉聘任不合格人員等","url":"https://stock-news.laohu8.com/highlight/detail?id=2665954553","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665954553?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:47","pubTimestamp":1788749245,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月7日讯，近日，国家金融监督管理总局大连监管局发布行政处罚决定书，剑指中国人民健康保险股份有限公司大连分公司及相关责任人。罚单显示，中国人民健康保险股份有限公司大连分公司的主要违法违规行为是：聘任不具有任职资格的人员；编制、提供虚假的报告报表文件资料。针对上述违法行为，国家金融监督管理总局大连监管局对中国人民健康保险股份有限公司大连分公司罚款27万元；对傅信弘警告，罚款7万元；对周笑俊警告，罚款7万元；对刘志东警告，罚款1万元；对李翔警告，罚款4万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788746879733984657","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4581","BK4588","LABU","BK4585","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665561483","title":"研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现，美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示，由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法，自2019年以来，美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童，结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","SG9999013999.USD","LU1366192091.USD","LU2063271972.USD","LU2112291526.USD","BK4599","IE00BK4W5L77.USD","LU2750360997.AUD","SG9999018865.SGD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU1280957306.USD","ELIS","LU2023250504.SGD","LU1868836591.USD","LU1979441026.SGD","LU0079474960.USD","LLYZ","LU0203202063.USD","LU0256863902.USD","LU1064131342.USD","LU1988902786.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU1323610961.USD","BK4581","LU2237443978.SGD","IE0004445015.USD","LU0683600562.USD","FHLC","LU2168564495.EUR","LU1551013425.SGD","LU2361044865.SGD","MEDX","LU2324357040.USD","MHIP","LU2237443465.HKD","BK4516","GB00BDT5M118.USD","IE0004445239.USD","LU1712237335.SGD","LU0133085943.USD","LU1720051108.HKD","SG9999014906.USD","LU2491050071.SGD","SGXZ57979304.SGD","RXL","LLY","IE0002141913.USD","BK4534","LU0882574055.USD","IE00BJLML261.HKD","LU2361045086.USD","LU2756315318.SGD","ELIL","LU0210536198.USD","LU2237443895.HKD","LU1145028129.USD","LU2237443382.USD","LU1267930730.SGD","LU2462591350.SGD","XLV","LU2108987350.USD","CURE","NVOC","OZEM","LU2211815571.USD","IE00BKPKM429.USD","LU2168564065.EUR","LU2089984988.USD","LU1974910355.USD","GDOC","LU2746668461.USD","LU2271345857.HKD","IHE","LU1804176565.USD","LU2023250330.USD","LU0174119429.USD","SG9999017495.SGD","LU0471298777.SGD","LU2168564149.EUR","TMED","LU1551013342.USD","LU0158827948.USD","BK4007","VHT","LU0266013472.USD","LU0006306889.USD","SG9999001176.USD","SG9999014880.SGD","LU0114720955.EUR","LU0417517546.SGD","LU1232071149.USD","LU2213496289.HKD","SGXZ31699556.SGD","LU0471298694.HKD","JDOC","SG9999015986.USD","IE00BJJMRY28.SGD","MEDI","NVOH","LU0456855351.SGD","LU0820561909.HKD","LU2028103732.USD","LU0889565916.HKD","SG9999014914.USD","SGXZ51526630.SGD","LU0820562030.AUD","LU2468319806.SGD","LU2471134952.CNY","LU2236285917.USD","IYH","LU0158827781.USD","LU0320765059.SGD","PJP","LU2750360641.GBP","LU1023059063.AUD","LU1989771016.USD","LU2168564222.USD","IE00BN29S564.USD","LU1093756168.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","THNR","SGXZ81514606.USD","LU0234572021.USD","SG9999015978.USD","LU2089284900.SGD","LLII","IE00B1XK9C88.USD","LU1691799644.USD","LU0353189763.USD","LU1061106388.HKD","IE00BWXC8680.SGD","LU2417539215.USD","NVO","LU1868837136.USD","IE00BFSS8Q28.SGD","LU0353189680.USD","LLYX","LU0122379950.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","IE00BZ1G4Q59.USD","LU1548497426.USD","SG9999014898.SGD","BK4585","IE0001KFT4U8.USD","LU0354030438.USD","LU0786609619.USD","LU1814569148.SGD","LU2552382215.SGD","LU2491050154.USD","LU0316494557.USD","LU0823434583.USD","BK4532","CANC","LU1069344957.HKD","LU2168563687.JPY","LU0097036916.USD","NVOX","IE00B4JS1V06.HKD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","LU0640476718.USD","LU0432979614.USD","WDNA","LU0154236417.USD","LU2237443622.USD","SGXZ99366536.SGD","LU1868837300.USD","LU1093756325.SGD","LU0094547139.USD","LU0109394709.USD","LU2023251221.USD","LU2552382132.HKD","SG9999015952.SGD","LU0823434740.USD","LU2237443549.SGD","LU0289739699.SGD","LU1720051017.SGD","LU0466842654.USD","LU0964807845.USD","LU0943347566.SGD","LU1868836757.USD","LU0238689110.USD","LU0320765992.SGD","LU0096364046.USD","LU0354030511.USD","LU0672654240.SGD","LU2361044949.HKD","IE0005OL40V9.USD","LU2357305700.SGD","LU2456880835.USD","LU0323591593.USD","LU0106261372.USD","LU2089283258.USD","IE00B1BXHZ80.USD","BK4588","FTXH","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","LU2491049909.HKD","PPH","IXJ","LU0820561818.USD","LU2265009873.SGD","LU2461242641.AUD","LU1035775433.USD","IE00BK4W5M84.HKD","LU0225283273.USD","LU1917777945.USD","TRUH","LU0058720904.USD","LU1057294990.SGD","LU2106854487.HKD","AGNG","LU1868836914.USD","LU2552382058.USD","LU1983299246.USD","SG9999001176.SGD","LU1623119135.USD","LU2602419157.SGD","IE00B775H168.HKD","LU0198837287.USD","LU2111349929.HKD","BK4533","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU2471134523.USD","LU2471134879.HKD","LU0109391861.USD","LU0823416689.USD","LU0787776722.HKD","LU1629891620.HKD","LU0345770993.USD","LU2087625088.SGD","SG9999018857.SGD","LU2746668974.SGD","IE0009355771.USD","LU0256863811.USD","SG9999015945.SGD","LU2237438978.USD","LU2360106947.USD","ILDR","LU1291159041.SGD","LU2896262040.SGD","LU0345770308.USD","HRTS","LU0203201768.USD","LU2471134796.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136673456","title":"醫療健康板塊動態：市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1136673456","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136673456?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 00:24","pubTimestamp":1788539073,"startTime":"0","endTime":"0","summary":"最新一期聚焦医疗健康领域的市场快讯已经发布，仅在道琼斯通讯社平台独家呈现，更新时段分别为美东时间凌晨4:20、中午12:20及下午4:50。分析师们认为，此项交易、上半年销售势头以及中国监管机构另行批准的进展，或将显著提升市场对和黄医药业绩指引的可见度。该公司预计2026年肿瘤学与免疫学领域收入将在3.3亿至4.5亿美元之间。目前该公司股价报22.60港元，涨幅为3.3%。以太坊上涨4.7%至2,506美元，瑞波币攀升7.4%至1.45美元，Solana则上涨4.8%至104.45美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334816","title":"丹陽家長注意！2027年度學生醫保繳費啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334816","media":"丹阳发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334816?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:05","pubTimestamp":1788523500,"startTime":"0","endTime":"0","summary":"为充分保障在校学生的医疗保险待遇，丹阳市2027年度学生参加城乡居民医疗保险的参保登记工作由学校统一为学生办理，个人缴费标准为450元，长期护理保险根据国家规定暂不单独筹资。被认定为资助参保救助对象的学生，可以选择参加认定地基本医疗保险，丹阳市救助学生个人缴费部分由社会医疗救助基金承担，个人无需缴费。同一年度第二次住院，起付标准按相应医疗机构级别标准降低50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-04/doc-iniqskun4096571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4588","XBI","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664380422","title":"一項針對僱主的調查預計，美國醫療保健成本將出現20多年來最大漲幅：2027年僱主提供的醫療保險成本預計將較今年上升8.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664380422","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664380422?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:43","pubTimestamp":1788511437,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4581","BK4585","XLV","MHIG","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161674237","title":"醫療板塊市場快訊：和黃醫藥與GSK達成許可協議，AstraZeneca新藥前景獲看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1161674237","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161674237?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:22","pubTimestamp":1788510155,"startTime":"0","endTime":"0","summary":"花旗分析师在报告中指出，和黄医药与葛兰素史克达成的合作协议，实际上是对这家总部位于香港的生物制药公司某一特定候选药物平台的价值背书——尽管该药物尚未进入临床试验阶段。此番和黄医药与GSK签署的授权协议，在剔除净销售额特许权使用费后，潜在交易总额最高可达12.95亿美元，标的为一种癌症治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}